Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.19 (
ubiquitin-protein ligase
)
799
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The GATA transcription factors GLN3 and GAT1 activate nitrogen-regulated genes in Saccharomyces cerevisiae.
NPR1
is a protein kinase that controls post-Golgi sorting of amino acid permeases. In the presence of a good nitrogen source, TOR (target of rapamycin) maintains GLN3 and
NPR1
phosphorylated and inactive by inhibiting the type 2A-related phosphatase SIT4. We identified
NPR1
as a regulator of GLN3. Specifically, loss of
NPR1
causes nuclear translocation and activation of GLN3, but not GAT1, in nitrogen-rich conditions.
NPR1
-mediated inhibition of GLN3 is independent of the phosphatase SIT4. We also demonstrate that the E3/E4
ubiquitin-protein ligase
proteins RSP5 and BUL1/2 are required for GLN3 activation under poor nitrogen conditions. Thus,
NPR1
and BUL1/2 antagonistically control GLN3-dependent transcription, suggesting a role for regulated ubiquitination in the control of nutrient-responsive transcription.
...
PMID:NPR1 kinase and RSP5-BUL1/2 ubiquitin ligase control GLN3-dependent transcription in Saccharomyces cerevisiae. 1524 35